Compare Nuwellis Inc (NUWE) vs TJX Companies Inc (TJX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuwellis Inc vs TJX Companies Inc — how do they compare? Nuwellis Inc trades at $0.8 (market cap $2.50M), while TJX Companies Inc trades at $126.5 (market cap $141.81B). The key difference: TJX Companies Inc is far larger — about 56724× Nuwellis Inc's market cap, and TJX Companies Inc pays a 1.49% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals.
| NUWE | TJX | |
|---|---|---|
Market Cap | $2.50M | $141.81B |
Sector | Technology | Consumer Cyclical |
52-Week High | $164.50 | $168.41 |
52-Week Low | $0.73 | $126.10 |
Enterprise Value | -$1.21M | $150.12B |
Dividend Yield | — | 1.49% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NUWE trades at $0.7878, up 0.88% today, but remains in a bearish technical trend. The company shows strong gross margins of 69.69% and double-digit revenue growth, but faces significant profitability challenges with negative net income margins and ROE. Recent developments include a reverse stock split, new CEO appointment, and strategic partnerships expanding pediatric care footprint.
While NUWE demonstrates operational progress with revenue growth and margin improvement, persistent losses and negative cash flow present substantial risk. The mixed analyst sentiment and bearish technical indicators suggest cautious approach. Investment appeal hinges on successful execution of financial efficiency strategy and path to profitability.
TJX Companies (TJX) trades at $128.91, down 2.4% over 24 hours, with technical indicators showing bearish momentum but oversold RSI signals. The company reported strong earnings beats in recent quarters, with Q2 2026 EPS of $1.22 exceeding expectations. Revenue grew to $56.36 billion in 2025, and net income margin improved to 9.73%. Analysts maintain a bullish consensus with 84.6% buy ratings and a $169 price target, citing expansion plans to 7,500 stores.
The outlook for TJX is positive due to consistent earnings outperformance and robust store growth strategy, though near-term stock pressure reflects valuation concerns and competitive comparisons. Key risks include market volatility and execution challenges in scaling operations. Investors may find opportunity in the current dip given strong fundamentals and analyst support.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →About TJX Companies Inc
TJX is a leading off-price retailer of apparel, home fashions, and other merchandise. It sells a variety of branded goods, opportunistically buying inventory from a network of over 21,000 vendors worldwide. TJX targets undercutting conventional retailers' regular prices by 20%-60%, capitalizing on a flexible merchandising network, relatively low-frills stores, and a treasure-hunt shopping experience to drive margins and inventory turnover. TJX derived 79% of fiscal 2022 revenue from the United States, with 11% from Europe (mostly the United Kingdom and Germany), 9% from Canada, and the remainder from Australia. The company operated 4,689 stores at the end of fiscal 2022 under the T.J. Maxx, T.K. Maxx, Marshalls, HomeGoods, Winners, Homesense, Winners, and Sierra banners.
Read more on TJX →
